“Covid-19: A combination of early stage drugs works (hydroxychloroquine, ivermectin). New study” By FranceSoir The year 2020 will have been marked by a series of studies on treatments against COVID-19 and associated controversies. All will remember the declarations of the Minister of Health and the Prime Minister that ” there is no treatment against Covid-19 ” despite […]
Tag: Covid-19
Problematic RCTs of hydroxychloroquine vs. COVID-19
By Erik Sass, TES Editor-in-Chief Following is a compilation of randomized controlled trials (and other types of studies) of hydroxychloroquine as a treatment for COVID-19, listing the flaws and errors which invalidate their conclusions. To add a trial entry or send corrections, please email TES Editor-in-Chief Erik Sass: eriksass@gmail.com . Boulware, et al. […]
Dr. Peter McCullough interviewed on health news censorship, the FDA, and more
Click on this link to hear an episode of Accad and Koka with an interview of Dr. Peter McCullough including an engaging review of early outpatient treatment of COVID-19, levels of evidence, inpatient treatment, and clinical outcomes across the globe in patients receiving care for COVID-19. The interview touches on controversial figures such as the […]
COVID-19 Will Cost the World $24.4 Trillion, And Recovery Will Be Very Uneven
“The International Monetary Fund reckons economic recovery for many countries will take a long time” By Lukas Rühli, courtesy of Avenir Suisse Almost eight months have passed since Avenir Suisse on March 9 discussed the IMF’s regular GDP forecasts and calculated the enormous economic downswings suffered by various countries since the start of the […]
Dr. Brian Tyson’s First-Person Account of Treating COVID-19 with Hydroxychloroquine
By Brian Tyson, MD We heard about a virus coming out of Wuhan, China, in January of 2020. I had a feeling it was going to makes its way to the US due to all the international travel. I told my wife Fabiola: we need to get prepared, and we are going to need […]
Africa must expand its clinical trial capacity
It would be an understatement to say that international coordination to the COVID-19 response has been wanting, with global organizations and national governments frequently at odds and confusion prevailing generally. The problems resulting from this lack of coordination are especially serious in low and middle-income countries (LMICs), notes Patrice Matchaba, Group Head of Global […]
What can drug companies do to combat racial disparities?
In light of the disproportionate toll COVID-19 has taken on ethnic minorities in the United States and elsewhere, public health authorities are making it a top priority to address racial disparities in healthcare provision and medical science. In an insightful new commentary for Politico, Tim Garnett, chief medical officer of Eli Lilly and Company, […]
Herrin: FDA Denying Patients Fundamental Freedom of Choice
By Christina Herrin, Director, Free to Choose Medicine As COVID-19 continues to wreak havoc across the United States, Americans need the freedom to try potentially life-saving medicines. Unfortunately, the U.S. FDA’s antiquated, rigidly bureaucratic structure is making this impossible – and it needs to change now. The Heartland Institute launched the Free […]
Washington Beyond the Headlines: Fighting Discrimination in School Funding
By Andy Blom, TES Washington Editor The Viral Rollercoaster — We unlock, we lock back down. Cases surge, deaths don’t. Schools to open, schools stay closed. It almost seems like politics and policy is rational and sane in comparison. Well, virus or no, Free Market policy people are working to offer better perspectives and […]
The race for CARES Act (taxpayer) broadband funds
By Johnny Kampis, Taxpayers Protection Alliance As the race for broadband funds from the CARES Act heats up, policy experts and taxpayer advocates hope the money ends up in the right place to help close the digital divide. The relief package, passed and signed into law in March, included $150 billion in relief […]